both sub $1 stocks with terrible management
another annual cost of 400k for an extra 9000 sq ft of office space they don't need. smh. inept management
bet your bottom dollar further delays are coming - not only pushing every thing back at least a quarter thanks to the FDA saying they need two large trials not one small fudged one, but they are having a hard time fully enrolling these trials. when that news hits investors will be done with this once and for all and will go to single digits - or sub 1 pre split, which is where it was heading. total.pump.and.dump.
trying to sneak in to phase III after such a terrible history in charge of this pos. plus hired two new expensive positions to help burn cash. going to 14s again, just as it did when the news of the FDA needing two trials hit market before the MMs manipulated to insiders could exercise options and the remaining big boys could dump on retail dumb money. see you in single digits when they announce further delays to the trial enrollment
it was all momo, pumping and window dressing. this was headed below $1 before this nonsense started and things have only gotten worse, not better. They trying to fool investors with the reverse split making it look like its worth something but things took a turn for the worse in this pos garbage when FDA DEMANDED not one small trial but TWO large trials. So now not only is this a pos but a pos that needs to find yet more money to conduct unexpected trials.
its just been the pun day and MM manipulation since then so the warrants could be exercised. Trials and therefore filing (if data is good) pushed back months at least. trials will be hard to fully enroll. more downside coming I'm afraid bag holders
if you didn't take profit ur an imbecile. if ur still a long suffering long who's underwater I'm sorry for u. cut losses and get short. prior to the pump day and MM manipulation so the warrants could be exercised this was in the 14s when FDA demands for two larger trials was released. its going there soon
there is no good news. the trial will get a further delay, guaranteed. FDA is very skeptical over this. And then theres the danger INCY or GWPH release data first which will devastate this stock. so much headwind ahead.
this is a pos, a garbage stock and company with laughable management.
if you didn't get back green after years of suffering losses you may never will. lots of headwinds up ahead. this action today should have you very worried
dilution the only solution
acquisition? bwhwhaaaa they can't even afford to keep the lights on come January
Reverse stock splits boost a company's share price. A higher share price is usually good, but the increase that comes from a reverse split is mostly an accounting trick. The company isn't any more valuable than it was before the reverse split. Whatever value it has is just distributed over fewer shares of stock, thus increasing the price. So a reverse split can generally be taken as a bad sign for a company.
Companies pull off reverse splits to keep their stock prices out of the cellar. In part, it's aesthetics and public relations: A stock price in the pennies-to-a-few-dollars range just looks bad. But there are also practical reasons: To remain listed on a major stock exchange, a company usually has to maintain a stock price above a certain level, often $1. ZGNX was scared and wary that the stock would fall below a buck, especially as the FDA trial delay news was looming.
Charles Kaplan, president of the investment consulting firm Equity Analytics, said, "It is usually a very negative sign when a company reverse splits their stocks."
its simp - do the math. they had $100m end of March with a guided burn of approx $51m before end of year as well s $26m in debt. FDA said no no no hang on there, we need two trials twice the size of what you were proposing, so the budget just went through the roof. So they originally planned to finish the year with less than $50m as well as a Phase 3 trial underway. Now they will finish with way less cash and two larger trials that may not even be fully enrolled by end of year. Dilution is 10000% coming as well as more delays. So much uncertainty behind this pump and dump
you are reading them wrong they are until years end. but i agree with the rest of what you say
Guidance for Q2 2105 – Q4 2015 (3)
$25 M - $28 M
$21 M – $23 M
I thought it was 50MM from Q2 to Q4, so 25MM/Q burn? maybe $75MM at hand now or less but with trial pushed back they will need money and soon for sure. they would be crazy not to do a raise here
no they only had 100 mill last count and their burn rate is high. plus these two new BIG trials are unforeseen and very expensive expenses that they didn't account for. plus at least another quarter delay means everything gets pushed back which costs money.
just the action of the last few days and the pump from the analyst tells me an offering is coming for sure